This is a routine drawdown under an existing credit facility with no new terms or material change in financial condition. Monitor the next quarterly filing for updates on total debt outstanding and cash runway, but no immediate trading action is warranted.
Price Chart
Executive Summary
TuHURA Biosciences drew an additional $1.5M from its existing $50M revolving credit facility with Parkview Holdings One LLC for general corporate purposes. This is a routine drawdown under a previously established facility, not a new debt arrangement, and does not signal a change in the company's financial condition or credit profile. The filing is administrative in nature with no material impact on the stock.
Key Facts
- TuHURA borrowed an additional $1.5M under its existing $50M revolving credit facility on September 2, 2026.
- The facility matures on April 21, 2031, and the funds will be used for general corporate purposes.
- The lender is Parkview Holdings One LLC, an affiliate of the company's largest stockholder, creating a potential conflict of interest.
- This is a routine drawdown under a facility disclosed in an April 22, 2026 8-K, not a new debt obligation.
Financial Impact
Additional $1.5M drawn from existing $50M revolving credit facility; total drawn amount not disclosed.
Risk Factors
- Potential conflict of interest as lender is an affiliate of the largest stockholder.
- Continued reliance on debt financing could signal insufficient cash from operations to fund development programs.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-383797 |
| Document: 0001193125-26-383797-index-headers.html | 0001193125-26-383797 |
| Document: 0001193125-26-383797-index.html | 0001193125-26-383797 |
| Document: 0001193125-26-383797.txt | 0001193125-26-383797 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 9d ago | 8-K | $1.78 | awaiting T+60 | — | $2.03 (+14.04%) |
Sep 24, 2026 4w ago | 8-K | $2.10 | awaiting T+60 | — | $2.03 (−3.33%) |
Sep 17, 2026 5w ago | 8-K | $2.10 | awaiting T+60 | — | $2.03 (−3.33%) |
Sep 16, 2026 5w ago | 8-K | $2.09 | awaiting T+60 | — | $2.03 (−2.87%) |
Sep 4, 2026 7w ago | 8-K | $2.12 | awaiting T+60 | — | $2.03 (−4.25%) |
Aug 19, 2026 9w ago | 8-K | $2.22 | awaiting T+60 | — | $2.03 (−8.56%) |
Aug 14, 2026 10w ago | 8-K | $2.47 | awaiting T+60 | — | $2.03 (−17.81%) |
Aug 14, 2026 10w ago | Press Release | $2.47 | awaiting T+60 | — | $2.03 (−17.81%) |
Aug 13, 2026 10w ago | 8-K | $2.47 | awaiting T+60 | — | $2.03 (−17.81%) |
Jul 29, 2026 12w ago | 8-K | $2.17 $2.18 | ▲ +0.46% | ▼ −2.00% | $2.03 (−6.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers